Treatment optimisation in drug development : study : Panel for the Future of Science and Technology / EPRS - European Parliamentary Research Service
Publication details: Brussels : European Union, March 2020Description: V, 70 p. ; 1 documento PDFContent type:- texto
- electrónico
- recurso en línea
- 978-92-846-6037-7
| Cover image | Item type | Current library | Home library | Collection | Shelving location | Call number | Materials specified | Vol info | URL | Copy number | Status | Notes | Date due | Barcode | Item holds | Item hold queue priority | Course reserves | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Informes
|
CDO | Colección digital | Acceso libre online | 1000020176024 |
Bibliografía: p. 66-70
The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner
Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.
There are no comments on this title.
Click on an image to view it in the image viewer